MRVL, DELL Fall & PATH Rises After Earnings, PFE Discontinues Weight Loss Pill

Marvell (MRVL) falls after issuing soft guidance. MRVL’s 3Q adjusted EPS came in at $0.41 versus an estimated $0.40 and revenue came in at $1.42B versus an estimated $1.40B. Dell (DELL) shares are down after mixed 3Q earnings. UiPath (PATH) opens at a new 52-week high after beating earnings. Its adjusted EPS came in at $0.12 versus an estimated $0.07 and revenue came in at $325.92M versus an estimated $315.54M. Pfizer (PFE) discontinues weight loss pill trial after many experienced negative side effects. Kevin Green discusses these stories. Tune in to find out more about the stock market today.